Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | January 08, 2025 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8DAD | 8DAD | SARS-CoV-2 receptor binding domain in complex with AZ090 Fab | |
| 7LDJ | P0DTC2 | SARS-CoV-2 receptor binding domain in complex with WNb-2 | |
| 7LDJ | 7LDJ | SARS-CoV-2 receptor binding domain in complex with WNb-2 | |
| 8XSL | P0DTC2 | SARS-CoV-2 spike + IMCAS-123 | |
| 8XSL | 8XSL | SARS-CoV-2 spike + IMCAS-123 | |
| 8OWT | 8OWT | SARS-CoV-2 spike RBD with A8 and H3 nanobodies bound | |
| 8OWT | P0DTC2 | SARS-CoV-2 spike RBD with A8 and H3 nanobodies bound | |
| 6VYB | P0DTC2 | SARS-CoV-2 spike ectodomain structure (open state) | |
| 8ELJ | P0DTC2 | SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 neutralizing antibody Fab fragment | |
| 8ELJ | 8ELJ | SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 neutralizing antibody Fab fragment | |
| 7Y71 | P0DTC2 | SARS-CoV-2 spike glycoprotein trimer complexed with Fab fragment of anti-RBD antibody E7 | |
| 7Y71 | 7Y71 | SARS-CoV-2 spike glycoprotein trimer complexed with Fab fragment of anti-RBD antibody E7 | |
| 7WGY | P0DTC2 | SARS-CoV-2 spike glycoprotein trimer in Intermediate state | |
| 7WGV | P0DTC2 | SARS-CoV-2 spike glycoprotein trimer in closed state | |
| 7WGX | P0DTC2 | SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L | |
| 7WGZ | P0DTC2 | SARS-CoV-2 spike glycoprotein trimer in open state | |
| 7KQB | P0DTC2 | SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I | |
| 7KQB | 7KQB | SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I | |
| 7UHC | P0DTC2 | SARS-CoV-2 spike in complex with AHB2-2GS-SB175 | |
| 7UHC | 7UHC | SARS-CoV-2 spike in complex with AHB2-2GS-SB175 | |
| 7UHB | P0DTC2 | SARS-CoV-2 spike in complex with AHB2-2GS-SB175 (local refinement of the RBD and AHB2) | |
| 7UHB | 7UHB | SARS-CoV-2 spike in complex with AHB2-2GS-SB175 (local refinement of the RBD and AHB2) | |
| 7JZL | P0DTC2 | SARS-CoV-2 spike in complex with LCB1 (2RBDs open) | |
| 7JZL | 7JZL | SARS-CoV-2 spike in complex with LCB1 (2RBDs open) | |
| 7JZU | 7JZU | SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) | |
| 7JZU | P0DTC2 | SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) | |
| 7JZN | P0DTC2 | SARS-CoV-2 spike in complex with LCB3 (2RBDs open) | |
| 7JZN | 7JZN | SARS-CoV-2 spike in complex with LCB3 (2RBDs open) | |
| 7JZM | 7JZM | SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) | |
| 7JZM | P0DTC2 | SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) | |
| 7KSG | P0DTC2 | SARS-CoV-2 spike in complex with nanobodies E | |
| 7KSG | 7KSG | SARS-CoV-2 spike in complex with nanobodies E | |
| 8HGL | P0DTC2 | SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 | |
| 8HGL | 8HGL | SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 | |
| 7YH7 | P0DTC2 | SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2) | |
| 7YH7 | 7YH7 | SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2) | |
| 8C89 | P0DTC2 | SARS-CoV-2 spike in complex with the 17T2 neutralizing antibody Fab fragment (local refinement of RBD and Fab) | |
| 8C89 | 8C89 | SARS-CoV-2 spike in complex with the 17T2 neutralizing antibody Fab fragment (local refinement of RBD and Fab) | |
| 7E3C | P0DTC2 | SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) | |
| 7E3C | 7E3C | SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) | |
| 7E39 | P0DTC2 | SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) | |
| 7E39 | 7E39 | SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) | |
| 7E23 | P0DTC2 | SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) | |
| 7E23 | 7E23 | SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) | |
| 7JVC | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | |
| 7JVC | 7JVC | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | |
| 7JVA | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | |
| 7JVA | 7JVA | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | |
| 7R7N | P0DTC2 | SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106) | |
| 7R7N | 7R7N | SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106) |
